Physician profile
Shantharam Darbe
NPI 1700950268
$1,313.77
in general payments reported to CMS, 2019-2025
16 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $368 · 2020: $135 · 2021: $811.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $418.70 | 2019-2021 | |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $289.19 | 2020-2021 | |
| Abbvie INC. | $147.36 | 2021 | |
| Alkermes, INC. | $87.40 | 2019-2021 | |
| Indivior INC. | $75.30 | 2019-2021 | |
| Takeda Pharmaceuticals U.S.A., INC. | $49.83 | 2021 | |
| Lundbeck LLC | $48.15 | 2019-2021 | |
| Vanda Pharmaceuticals INC. | $41.38 | 2019 | |
| Allergan, INC. | $32.76 | 2019 | |
| Sunovion Pharmaceuticals INC. | $25.21 | 2021 | |
| Bausch Health US, LLC | $22.00 | 2021 | |
| Eisai INC. | $17.71 | 2020 | |
| Otsuka America Pharmaceutical, INC. | $17.43 | 2021 | |
| Sun Pharmaceutical Industries INC. | $15.77 | 2021 | |
| Vertical Pharmaceuticals, LLC | $12.82 | 2020 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Teva Pharmaceuticals USA, INC. | $12.76 | 2020 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Shantharam Darbe listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.